4. Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006;103(2):714-8. [
DOI:10.1016/j.ygyno.2006.03.055] [
PMID]
6. AJ BS, Fader A, Tanner E. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol. 2016;216(5):459-76. e10. [
DOI:10.1016/j.ajog.2016.11.1033] [
PMID]
7. Allameh T, Hashemi V, Mohammadizadeh F, Behnamfar F. Sentinel lymph node mapping in early stage of endometrial and cervical cancers. J Res Med Sci. 2015;20(2):169-73.
8. Bats A-S, Buénerd A, Querleu D, Leblanc E, Daraï E, Morice P, et al. Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: a prospective, multicenter study. Gynecol Oncol. 2011;123(2):230-5. [
DOI:10.1016/j.ygyno.2011.08.010] [
PMID]
9. Raimond E, Ballester M, Hudry D, Bendifallah S, Daraï E, Graesslin O, et al. Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: Results of a retrospective multicenter study. Gynecol Oncol. 2014;133(3):506-11. [
DOI:10.1016/j.ygyno.2014.03.019] [
PMID]
10. Touhami O, Trinh XB, Gregoire J, Sebastianelli A, Renaud MC, Grondin K, et al. Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer. Gynecol Oncol. 2015;138(1):41-5. [
DOI:10.1016/j.ygyno.2015.04.008] [
PMID]
11. Vidal F, Leguevaque P, Motton S, Delotte J, Ferron G, Querleu D, et al. Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting. Int J Gynecol Cancer. 2013;23(7):1237-43. [
DOI:10.1097/IGC.0b013e31829b1b98] [
PMID]
12. Sawicki S, Lass P, Wydra D. Sentinel Lymph Node Biopsy in Endometrial Cancer--Comparison of 2 Detection Methods. Int J Gynecol Cancer. 2015;25(6):1044-50. [
DOI:10.1097/IGC.0000000000000447] [
PMID]
13. Basta A, Pityński K, Basta P, Hubalewska-Hoła A, Opławski M, Przeszlakowski D. Sentinel node in gynaecological oncology. Reports of Practical Oncology and Radiotherapy. 2005;10(2):24-7. [
DOI:10.1016/S1507-1367(05)71114-7]
14. Buda A, Crivellaro C, Elisei F, Di Martino G, Guerra L, De Ponti E, et al. Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer (99m)Tc and/or Blue Dye. Ann Surg Oncol. 2016;23(7):2183-91. [
DOI:10.1245/s10434-015-5022-1] [
PMID] [
PMCID]
15. Tanner EJ, Sinno AK, Stone RL, Levinson KL, Long KC, Fader AN. Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer. Gynecol Oncol. 2015;138(3):542-7. [
DOI:10.1016/j.ygyno.2015.06.024] [
PMID]
16. Daraï E, Dubernard G, Bats A-S, Heitz D, Mathevet P, Marret H, et al. Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study. Gynecol oncol. 2015;136(1):54-9. [
DOI:10.1016/j.ygyno.2014.09.011] [
PMID]
17. Farghali MM, Allam IS, Abdelazim IA, El-Kady OS, Rashed AR, Gareer WY, et al. Accuracy of Sentinel Node in Detecting Lymph Node Metastasis in Primary Endometrial Carcinoma. Asian Pac J Cancer Prev APJCP. 2015;16(15):6691-6. [
DOI:10.7314/APJCP.2015.16.15.6691] [
PMID]
18. Lin H, Ding Z, Kota VG, Zhang X, Zhou J. Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(28):46601. [
DOI:10.18632/oncotarget.16662] [
PMID] [
PMCID]
19. Kuru O, Topuz S, Sen S, Iyibozkurt C, Berkman S. Sentinel lymph node biopsy in endometrial cancer: description of the technique and preliminary results. J Turk Ger Gynecol Assoc. 2011;12(4):204-8. [
DOI:10.5152/jtgga.2011.52] [
PMID] [
PMCID]
20. Kadkhodayan S, Shiravani Z, Hasanzadeh M, Sharifi N, Yousefi Z, Fattahi A, et al. Lymphatic mapping and sentinel node biopsy in endometrial cancer--a feasibility study using cervical injection of radiotracer and blue dye. Nucl Med Rev Cent East Eur. 2014;17(2):55-8. [
DOI:10.5603/NMR.2014.0017] [
PMID]
21. Gien LT, Kwon JS, Carey MS. Sentinel node mapping with isosulfan blue dye in endometrial cancer. J Obstet Gynaecol Can. 2005;27(12):1107-12. [
DOI:10.1016/S1701-2163(16)30393-0] [
PMID]
22. Eitan R, Sabah G, Krissi H, Raban O, Ben-Haroush A, Goldschmit C, et al. Robotic blue-dye sentinel lymph node detection for endometrial cancer - Factors predicting successful mapping. Eur J Surg Oncol. 2015;41(12):1659-63. [
DOI:10.1016/j.ejso.2015.09.006] [
PMID]
23. Koskas M, Chereau E, Ballester M, Dubernard G, Lécuru F, Heitz D, et al. Accuracy of a nomogram for prediction of lymph-node metastasis detected with conventional histopathology and ultrastaging in endometrial cancer. Bri J Cancer. 2013;108(6):1267-72. [
DOI:10.1038/bjc.2013.95] [
PMID] [
PMCID]
24. Niikura H, Kaiho-Sakuma M, Tokunaga H, Toyoshima M, Utsunomiya H, Nagase S, et al. Tracer injection sites and combinations for sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol. 2013;131(2):299-303. [
DOI:10.1016/j.ygyno.2013.08.018] [
PMID]
25. Selman TJ, Mann CH, Zamora J, Khan KS. A systematic review of tests for lymph node status in primary endometrial cancer. BMC women's health. 2008;8:8. [
DOI:10.1186/1472-6874-8-8] [
PMID] [
PMCID]
26. Ruscito I, Gasparri ML, Braicu EI, Bellati F, Raio L, Sehouli J, et al. Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes-A Meta-Analysis. Ann Surg Oncol. 2016;23(11):3749-56. [
DOI:10.1245/s10434-016-5236-x] [
PMID]